dihexa renal toxicity Suggested mechanisms of doxorubicin induced nephropathy. A single Pathway-based network medicine identifies novel
Description
Composition and formatBPC-157 (10 mg) is a synthetic pentadecapeptide supplied as 10 mg per vial for controlled laboratory workflows
Used both topically and as an injectable
Allow the peptide to dissolve gradually without shaking or agitating the vial
1,3 Angiogenesis inhibitors work by specifically recognizing and binding to VEGF so that VEGF is unable to activate the VEGF receptor to stimulate the growth of new blood vessels
You will inject 1mL daily for 30 days
